Arecor market cap soars to c$100m after IPO

Cambridge biopharma business Arecor made a stunning bow on London’s AIM market today as its share price immediately grew wings.

At one stage in the early flurry of dealings the market cap had soared to $98.9 million.

The stock debuted at 226p but peaked at 250p at the height of activity: As exclusively predicted in Business Weekly mid-May, the UK business raised £20 million in an oversubscribed round.

Arecor is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products.

Read the full story by Tony Quested of Business Weekly here

Looking for something specific?